{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:12:24Z","timestamp":1790190744507,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004964","name":"European Commission","doi-asserted-by":"publisher","award":["242210"],"award-info":[{"award-number":["242210"]}],"id":[{"id":"10.13039\/501100004964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004964","name":"European Commission","doi-asserted-by":"publisher","award":["FP7 REGPOT-2010-1"],"award-info":[{"award-number":["FP7 REGPOT-2010-1"]}],"id":[{"id":"10.13039\/501100004964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004964","name":"European Commission","doi-asserted-by":"publisher","award":["264083"],"award-info":[{"award-number":["264083"]}],"id":[{"id":"10.13039\/501100004964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004952","name":"MDA","doi-asserted-by":"publisher","award":["MDA255236"],"award-info":[{"award-number":["MDA255236"]}],"id":[{"id":"10.13039\/100004952","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Greek NSRF"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jneuroim.2014.12.001","type":"journal-article","created":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T05:05:10Z","timestamp":1417583110000},"page":"19-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Specific adsorbents for myasthenia gravis autoantibodies using mutants of the muscle nicotinic acetylcholine receptor extracellular domains"],"prefix":"10.1016","volume":"278","author":[{"given":"K.","family":"Lazaridis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Evaggelakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bentenidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sideri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Grapsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2014.12.001_bb0005","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2008.05.026","article-title":"Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients","volume":"201\u2013202","author":"Baggi","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/039139889401701109","article-title":"Removal of antiacetylcholine receptor antibodies by protein-A immunoadsorption in myasthenia gravis","volume":"17","author":"Berta","year":"1994","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0015","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.bbapap.2008.04.023","article-title":"Mutant forms of the extracellular domain of the human acetylcholine receptor gamma-subunit with improved solubility and enhanced antigenicity. The importance of the cys-loop","volume":"1784","author":"Bitzopoulou","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0020","doi-asserted-by":"crossref","first-page":"40207","DOI":"10.1074\/jbc.R112.407668","article-title":"The nicotinic acetylcholine receptor: the founding father of the pentameric ligand-gated ion channel superfamily","volume":"287","author":"Changeux","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0025","first-page":"847393","article-title":"Myasthenia gravis: a review of available treatment approaches","volume":"2011","author":"Gilhus","year":"2011","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/08916930903555943","article-title":"Antibody effector mechanisms in myasthenia gravis \u2014 pathogenesis at the neuromuscular junction","volume":"43","author":"Gomez","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0040","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1111\/j.1742-4658.2006.05363.x","article-title":"Expression and characterization of soluble forms of the extracellular domains of the beta, gamma and epsilon subunits of the human muscle acetylcholine receptor","volume":"273","author":"Kostelidou","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2007.07.018","article-title":"Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency","volume":"190","author":"Kostelidou","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.11.001","article-title":"Scale up and safety parameters of antigen specific immunoadsorption of human anti-acetylcholine receptor antibodies","volume":"267","author":"Lagoumintzis","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijbiomac.2013.11.003","article-title":"Expression of human AChR extracellular domain mutants with improved characteristics","volume":"63","author":"Lazaridis","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0055","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.144.3.739","article-title":"Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0060","doi-asserted-by":"crossref","first-page":"13898","DOI":"10.1523\/JNEUROSCI.2833-09.2009","article-title":"Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity","volume":"29","author":"Luo","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1525-1594.2000.06490.x","article-title":"Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: evaluation of 602 sessions of extracorporeal immunoadsorption","volume":"24","author":"Matic","year":"2000","journal-title":"Artif. Organs"},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0065","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1526-0968.2001.00370.x","article-title":"Background and indications for protein A-based extracorporeal immunoadsorption","volume":"5","author":"Matic","year":"2001","journal-title":"Ther. Apher."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0075","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0080","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(79)90823-7","article-title":"Long-term effects of repeated plasma exchange in myasthenia gravis","volume":"1","author":"Newsom-Davis","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.10.002","article-title":"Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy","volume":"159","author":"Psaridi-Linardaki","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.transci.2003.11.005","article-title":"Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis","volume":"30","author":"Ptak","year":"2004","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0095","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3109\/08916930903518107","article-title":"Immunosuppressive therapies in myasthenia gravis","volume":"43","author":"Sanders","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0100","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-4159.2010.07060.x","article-title":"Assembly of nicotinic and other cys-loop receptors","volume":"116","author":"Tsetlin","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.77.2.755","article-title":"Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits","volume":"77","author":"Tzartos","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jmb.2004.12.031","article-title":"Refined structure of the nicotinic acetylcholine receptor at 4A resolution","volume":"346","author":"Unwin","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0115","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2014.12.001_bb0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneuroim.2008.06.002","article-title":"Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains","volume":"200","author":"Zisimopoulou","year":"2008","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572814009850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572814009850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:23:27Z","timestamp":1759047807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572814009850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":24,"alternative-id":["S0165572814009850"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.12.001","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific adsorbents for myasthenia gravis autoantibodies using mutants of the muscle nicotinic acetylcholine receptor extracellular domains","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}